The Impact of Mild Chronic Stress and Maternal Experience in the <i>Fmr1</i> Mouse Model of Fragile X Syndrome

The Impact of Mild Chronic Stress and Maternal Experience in the <i>Fmr1</i> Mouse Model of Fragile X Syndrome

Fragile X syndrome (FXS) is a pervasive developmental disorder and the most common monogenic cause of autism spectrum disorder (ASD). Female heterozygous (HET) carriers play a major role in the transmission of the pathology and present several FXS- and ASD-like behavioral alterations. Despite their...

Full description

Bibliographic Details
Main Authors:	Enejda Subashi, Valerie Lemaire, Valeria Petroni, Susanna Pietropaolo
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	International Journal of Molecular Sciences
Subjects:	neurodevelopmental disorders unpredictable stress ultrasonic communication Fmr1 maternal care
Online Access:	https://www.mdpi.com/1422-0067/24/14/11398

Similar Items

Long-term behavioral effects of prenatal stress in the Fmr1-knock-out mouse model for fragile X syndrome
by: Valeria Petroni, et al.
Published: (2022-10-01)

Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the <i>Fmr1</i>-KO Mouse Model of Fragile X Syndrome
by: Marika Premoli, et al.
Published: (2023-07-01)

Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)
by: Maria Isabel Alvarez-Mora, et al.
Published: (2022-04-01)

Development and validation of a single‐tube multiplex PCR for rapid screening of Fragile X and Fragile XE syndromes of FMR1 and FMR2 genes
by: Areerat Hnoonual, et al.
Published: (2021-06-01)

Fragile X Syndrome Caused by Maternal Somatic Mosaicism of <i>FMR1</i> Gene: Case Report and Literature Review
by: Maria Jose Gómez-Rodríguez, et al.
Published: (2022-09-01)

Autistic-like behavioral effects of prenatal stress in juvenile Fmr1 mice: the relevance of sex differences and gene–environment interactions
by: Valeria Petroni, et al.
Published: (2022-05-01)

Hyperacusis in the Adult <i>Fmr1</i>-KO Mouse Model of Fragile X Syndrome: The Therapeutic Relevance of Cochlear Alterations and BKCa Channels
by: Celeste Ferraguto, et al.
Published: (2023-07-01)

Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on <i>FMR1</i> Premutation
by: Flora Tassone, et al.
Published: (2023-09-01)

Fragile X syndrome - insight into what we know and prospects
by: Adam Strzoda, et al.
Published: (2023-04-01)

Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding
by: Eleonora eNapoli, et al.
Published: (2016-04-01)

Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)
by: Ellery Santos, et al.
Published: (2023-12-01)

Structure and stability upon maternal transmission of common and intermediate FMR1 (Fragile X Mental Retardation 1) alleles in a sample of the Brazilian population
by: Leonardo P. Capelli, et al.
Published: (2005-03-01)

Efficient Delivery of <i>FMR1</i> across the Blood Brain Barrier Using AAVphp Construct in Adult <i>FMR1</i> KO Mice Suggests the Feasibility of Gene Therapy for Fragile X Syndrome
by: Kathryn K. Chadman, et al.
Published: (2023-02-01)

Early Neurobehavioral Characterization of the CD Mouse Model of Williams–Beuren Syndrome
by: Silvia Giannoccaro, et al.
Published: (2023-01-01)

Defining the 3′Epigenetic Boundary of the <i>FMR1</i> Promoter and Its Loss in Individuals with Fragile X Syndrome
by: David E. Godler, et al.
Published: (2023-06-01)

FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve
by: Julia Rehnitz, et al.
Published: (2018-07-01)

DNA Methylation, Mechanisms of <i>FMR1</i> Inactivation and Therapeutic Perspectives for Fragile X Syndrome
by: Veronica Nobile, et al.
Published: (2021-02-01)

Altered cortical Cytoarchitecture in the Fmr1 knockout mouse
by: Frankie H. F. Lee, et al.
Published: (2019-06-01)

The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo
by: E.J. Mientjes, et al.
Published: (2006-03-01)

Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
by: Cedrik Tekendo-Ngongang, et al.
Published: (2021-10-01)

EZH2 inhibition reactivates epigenetically silenced FMR1 and normalizes molecular and electrophysiological abnormalities in fragile X syndrome neurons
by: Minggang Fang, et al.
Published: (2024-02-01)

Arbaclofen in fragile X syndrome: results of phase 3 trials
by: Elizabeth Berry-Kravis, et al.
Published: (2017-06-01)

Effect of Social Odor Context on the Emission of Isolation-induced Ultrasonic Vocalizations in the BTBR T+tf/J Mouse Model for Autism
by: Markus eWöhr
Published: (2015-03-01)

Prenatal Diagnosis of Fragile X: Can a Full Mutation Allele in the FMR1 Gene Contract to a Normal Size?
by: Esther Manor, et al.
Published: (2017-11-01)

Applying the FMR Technique to Analyzing the Influence of Nitriding on the Magnetic Properties of Steel
by: Slawomir Maksymilian Kaczmarek, et al.
Published: (2022-06-01)

A Genotype-Phenotype Study of High-Resolution <i>FMR1</i> Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments
by: Dejan B. Budimirovic, et al.
Published: (2020-09-01)

Parallel learning and cognitive flexibility impairments between Fmr1 knockout mice and individuals with fragile X syndrome
by: Lauren M. Schmitt, et al.
Published: (2023-01-01)

Metabolic Alterations in FMR1 Premutation Carriers
by: Yiqu Cao, et al.
Published: (2020-09-01)

Comparative Behavioral Phenotypes of Fmr1 KO, Fxr2 Het, and Fmr1 KO/Fxr2 Het Mice
by: Rachel Michelle Saré, et al.
Published: (2019-01-01)

Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
by: Scott Thomas, et al.
Published: (2021-11-01)

Effect of AGG Interruptions on FMR1 Maternal Transmissions
by: Olatz Villate, et al.
Published: (2020-07-01)

PGT-M for Premature Ovarian Failure Related to CGG Repeat Expansion of the <i>FMR1</i> Gene
by: Tiziana Persico, et al.
Published: (2023-12-01)

High performing male with fragile X syndrome with an unmethylated FMR1 full mutation: The relevance of clinical and genetic correlations
by: Meg Shieh, et al.
Published: (2023-06-01)

Tophaceous gout of the nose in a male FMR1 premutation carrier
by: Si Jie Tang, et al.
Published: (2022-11-01)

The Use of “Retardation” in FRAXA, FMRP, FMR1 and Other Designations
by: Jonathan Herring, et al.
Published: (2022-03-01)

Novel Features of dFMR1, the Drosophila Orthologue of the Fragile X Mental Retardation Protein
by: Annette Schenck, et al.
Published: (2002-10-01)

Gene therapy using human FMRP isoforms driven by the human FMR1 promoter rescues fragile X syndrome mouse deficits
by: Yiru Jiang, et al.
Published: (2022-12-01)

High Throughput Small Molecule Screen for Reactivation of <i>FMR1</i> in Fragile X Syndrome Human Neural Cells
by: Jack F. V. Hunt, et al.
Published: (2021-12-01)

Static and dynamic postural control deficits in aging fragile X mental retardation 1 (FMR1) gene premutation carriers
by: Zheng Wang, et al.
Published: (2019-01-01)

Pharmacological Reactivation of the Silenced <i>FMR1</i> Gene as a Targeted Therapeutic Approach for Fragile X Syndrome
by: Daman Kumari, et al.
Published: (2019-02-01)